(Q45151580)

10 December 2017

title

Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

10 December 2017

0 references

1 reference

Hindorf U

1

1 reference

10 December 2017

Lyrenäs E

series ordinal

2

1 reference

10 December 2017

Nilsson A

series ordinal

3

1 reference

10 December 2017

Schmiegelow K

series ordinal

4

1 reference

10 December 2017

publication date

1 November 2004

1 reference

Scandinavian Journal of Gastroenterology

10 December 2017

published in

1 reference

10 December 2017

volume

39

1 reference

10 December 2017

issue

11

1 reference

10 December 2017

page(s)

1105-1112

1 reference

A controlled trial of azathioprine in Crohn's disease

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

A controlled double blind study of azathioprine in the management of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in a patient receiving thiopurine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520410007980

10.1080/00365520410007980

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference